Skip to main content
HighlightsHighlights Archive

Media Monitoring: May 30 – June 5

By June 5, 2024No Comments

An update on the ongoing NHS-Galleri trial

  • Based on data from the first year of the three-year NHS-Galleri trial, NHS England has decided that it will wait to see final results, expected in 2026, before considering whether an NHS rollout of the Galleri multi cancer early detection test (the Multi Cancer Blood Test Programme, MCBT) should go ahead.
  • Many successful cancer screening trials have failed to show a stage shift initially, and it is frequently observed that the first-year data will differ from the final trial results.
  • NHS England has reviewed preliminary data from the first year of the NHS-Galleri trial and did not find them compelling enough to justify proceeding straight away with a large-scale pilot programme of the test in NHS clinical practice.


At-home saliva test may catch deadly prostate cancers

  • Saliva tests carried out at home are better at identifying men who are at higher risk of prostate cancer than the standard blood test, new research suggests.
  • The at-home test could identify genetic factors which make men more likely to develop the disease which claims around 12,000 lives a year in the UK.
  • The study was carried out by the Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust.


UKHSA health security campus: Costs rise by 500% as project at least 15 years behind schedule, PAC warns

  • Seven years after the £30 million purchase of a site in Harlow, it remains unclear where the UK’s new high containment public health laboratories will be built.
  • Despite having produced multiple business cases, UKHSA and DHSC are yet to agree the full scope of the programme or the extent to which UKHSA will work with other government departments with a need for high containment laboratories.
  • If the programme does not progress at Harlow, at least £295 million of taxpayer money will be written off.


Melanoma skin cancer cases rising in UK

  • Cancer Research UK predicts there will be a record 20,800 cases diagnosed this year – up from a yearly average of 19,300 between 2020 and 2022.
  • Its analysis shows rates rose by almost a third, external between 2009 and 2019 – from 21 to 28 cases per 100,000 people.
  • The rise in diagnoses is due partly to a growing ageing population and an increase in awareness of the signs of skin cancer.


Incoming government will have ‘mountain to climb’ to reverse unequal NHS funding trends, says think tank

  • The Nuffield Trust says that successive governments have “not put their money where their mouths are” when it comes to prevention and moving care further upstream into communities.
  • Needs-adjusted spending in NHS community health services was 4.2% below what it was in 2016/17 – the equivalent of £6 less per person.


What could ‘personalised prevention’ mean for our health? – Health Foundation report


Melanoma skin cancer vaccine being trialled on NHS halves risk of death or relapse (paywall)

Ben Kemp